Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

SillaJen to acquire Jennerex

Nov. 29, 2013

Genmab reaches milestone in Janssen Biotech collaboration

Nov. 27, 2013

Lytix Biopharma enrolls first patient in study of LTX-315

Nov. 27, 2013

E39 is well tolerated in patients with endometrial and ovarian cancer

Nov. 27, 2013

F-star generates an Fcab antibody against HER2

Nov. 21, 2013

Innate Pharma initiates program to develop anti-MICA antibody

Nov. 21, 2013

European approval for Kadcyla

Nov. 20, 2013

Generex Biotechnology reaches prespecified point in phase II trial of breast cancer vaccine

Nov. 19, 2013

First patient treated in study of DNX-2401 and temozolomide for recurrent glioblastoma

Nov. 15, 2013

Roche and immatics biotechnologies sign cancer vaccine collaboration

Nov. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.